Thymoglobulin rabbit anti-thymocyte globulin: NDA submitted; Phase III data presented

Twelve-month results of a Phase III trial of Thymoglobulin in 162 patients showed survival rates were similar to those with Atgam horse anti-thymocyte globulin, and that less recurrent rejection foll...